Blockade of foam cell formation by an AP-1 inhibitor attenuates atherosclerosis in diabetes

Back

ESC2024 Premium Access

Blockade of foam cell formation by an AP-1 inhibitor attenuates atherosclerosis in diabetes

Session: Atherosclerosis and inflammation

Topic: Atherosclerosis, Cerebrovascular Diseases, Aneurysm, Restenosis

Speaker: Doctor A. Khan (Melbourne, AU)

Event: ESC Congress 2024

Congress Presentation

About the speaker

Doctor Abdul Waheed Khan

Monash University, Melbourne (Australia)

0 follower

6 more presentations in this session

Monocyte response to mitochondrial DAMPs in elderly subjects: a possible contribution to chronic inflammation and atherosclerosis

Speaker: Professor A. Mattioli (Bologna, IT)

Deletion of the asialyloglycoprotein receptor-1 (ASGR1) causes atheroprotective effects in vitro and in vivo

Speaker: Associate Professor C. Bursill (Adelaide, AU)

Access

Abstract

Slides

Macrophages overexpressing interleukin-10 target and prevent atherosclerosis: regression of plaque formation and reduction in necrotic core

Speaker: Doctor M. Wang (Beijing, CN)

Access

Abstract

Slides

C-C motif chemokine ligand 3 is associated with atherosclerotic plaque vulnerability and increased risk of mortality

Speaker: Doctor Y. Li (Malmo, SE)

Access

Abstract

Slides

Combined administration of atorvastatin and mesenchymal stem cells synergizes to attenuate inflammation and promote efferocytosis in atherosclerotic mice

Speaker: Mr Q. Pan (Beijing, CN)

Access the full session

Atherosclerosis and inflammation

Speakers: Doctor A. Khan, Professor A. Mattioli, Associate Professor C. Bursill, Doctor M. Wang, Doctor Y. Li...

Access

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources